 |
 |
 |
|
 |
What's New |
 |
|
 |
- Jeffrey Kindler, Pfizer CEO and Chairman of the Board and Joshua M. Sharfstein, M.D., FDA Principal Deputy Commissioner to speak at Partnering for Cures Plenary Sessions
- View program schedule, session descriptions and confirmed speaker
- View list of the 42 nonprofits presenting their assets, capabilities, and research & development strategy
- Philanthropists, Medical Research Foundations, and Industry Leaders Gather in New York for Inaugural Partnering for Cures Meeting
|
 |
 |
 |
 |
|
|
| Partnering for Cures is a first-of-its-kind meeting that will bring together philanthropy, medical research foundations, and the biopharmaceutical industry in an effort to forge strategic collaborations key to the timely development of new medical solutions. It's designed to combine the outcomes-oriented approach of investor conferences, the networking opportunities at biopharmaceutical industry "partnering" meetings, and the knowledge sharing that drives patient advocacy events.
Register today and become an involved and empowered partner in medical research. Partnering for Cures will
- feature program sessions with the most forward-thinking leaders in medical research and development;
- build on best practices gleaned from investor conferences, providing nonprofit foundations with the opportunity to present their novel approaches to pursuing outcomes-driven research; and
- bring stakeholders together through a partnering system that has paved the way for biotechnology and pharmaceutical companies to build partnerships.
This meeting unites the power of philanthropy, the passion of medical research foundations, and the expertise of biotechnology and pharmaceutical companies to catalyze a more effective and efficient medical research enterprise.
|
|
 |
 |
- Learn about how nonprofits are pursuing innovative, high-risk research with the potential for high-rewards
- Identify and meet with research organizations whose mission and strategies match your philanthropic priorities
- Cultivate relationships with and learn from the experiences of other supporters of medical research
|
|
 |
- Present your cutting-edge approach to science and medical research
- Find the right partners and investors to turn a scientific discovery into an accessible therapy
- Learn from other nonprofits with creative approaches to research, robust research portfolios, and successful partnership models
|
|
 |
- Learn about new collaboration models producing results
- Identify the development potential of nonprofit's novel research efforts
- Build relationships with key players transforming the therapeutic development enterprises
|
|
 |
- Meet medical foundations and clinical experts with deep knowledge of therapeutic fields, clinical options, research frontiers and broad pipeline perspectives
- Identify and evaluate novel product candidates and technologies that will complement or extend portfolio company pipelines
- Explore strategies for non-dilutive funding
|
|
